top of page

IGS2021 Start Up Showcase Bridge Therapeutics, Inc

Tim Peara President of Bridge Therapeutics

Bridge Therapeutics, Inc. is a development-stage pharmaceutical company pursuing FDA approval of BT‑219 for Opioid Use Disorder (OUD), and BT-205 for the treatment of chronic pain in opioid experienced patients.

11 views0 comments

Recent Posts

See All

Comentários


bottom of page